A carregar...

EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Introduction: The mechanism of EphB4/ephrinB2 in the resistance of chronic myelogenous leukemia to imatinib keeps unknown. Methods: The imatinib resistant chronic myelogenous leukemia cell line-K562-R, was established. EphB4 receptor expression was detected in patients and resistant cells. Cell migr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Med Sci
Main Authors: Li, Lin, Xu, Na, Zhang, Jin-fang, Xu, Lu-lu, Zhou, Xuan, Huang, Bin-tao, Li, Yu-ling, Liu, Xiao-li
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879769/
https://ncbi.nlm.nih.gov/pubmed/27226777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.14989
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!